Hepatitis C treatment is not reaching some at-risk populations
Two recent studies from researchers at WashU Medicine reveal that two vulnerable populations — children and recently pregnant women — face disparities in access to treatment for hepatitis C infection, putting them at risk of long-term health problems.
WashU molecular biologists identify multifunctional virus-sensing protein
WashU Medicine researchers led by Siyuan Ding identified an immune-system protein in human cells that has the unusual capacity to respond to both DNA and RNA from pathogens, which may have implications for developing vaccines.
WashU Medicine develops new postbaccalaureate training program
WashU Medicine faculty members received funding from the National Institutes of Health (NIH) to develop the Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases, a two-year mentored research experience.
Region’s first patient receives sickle cell gene therapy
The first sickle cell disease patient in the St. Louis region has been successfully treated by WashU Medicine physicians at St. Louis Children’s Hospital with a gene therapy newly approved by the Food and Drug Administration.
Ornitz receives NIH grant to study lung development
The National Institutes of Health (NIH) has awarded David M. Ornitz, MD, PhD, of WashU Medicine, $740,000 annually for four years to support research aimed at understanding respiratory complications associated with premature birth.
Sleep data from wearable device may help predict preterm birth
An interdisciplinary research team at Washington University in St. Louis has found that variability in sleep patterns in people experiencing pregnancy can effectively predict preterm birth.
Harris selected for William T. Grant Scholar Class of 2030
Occupational therapy faculty member Kelly Harris, at WashU Medicine, will receive a $425,000 award to develop and test a technology-enabled care coordination service model to support Black youth with asthma.
AI-based brain-mapping software receives FDA market authorization
The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.
Predicting pain with machine learning
Researchers at Washington University in St. Louis are using machine learning to better predict who will experience persistent pain after surgery.
$12 million grant funds studies of role of genes in autism, similar diagnoses
Researchers at WashU Medicine received a $12 million National Institutes of Health (NIH) grant to deepen understanding of autism and other neurodevelopmental and psychiatric disorders that are caused by a single gene mutation.
Older Stories